Browsing: Therapeutics

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide

Viking Therapeutics (VKTX) is up 8.9% today. Here is some analysis on what might have caused this price movement

Existing data supports direct path to resubmission following constructive FDA engagement

WALTHAM, Mass., July 07, 2026 (GLOBE NEWSWIRE) — Kailera Therapeutics, Inc. (Kailera), a clinical-stage biotechnology company focused on elevating the next era of obesity care, today announced positive topline data from two additional Phase 3 clinical trials of oral small molecule GLP-1 receptor agonist HRS-7535 (also known as KAI-7535) conducted by Hengrui Pharma: the Phase…